Showing 2171-2180 of 2735 results for "".
- 2025 AAD: Physosocial Implications of Neuromodulator Injectionshttps://modernaesthetics.com/news/2025-aad-physosocial-implications-of-neuromodulator-injections/2473760/The “Botulinum Toxins: The Latest Updates” session at the 2025 American Academy of Dermatology (AAD) Annual Meeting concluded with Vince Bertucci, MD, FAAD, discussing the topic of “Physosocial Implications of Neuromodulator Injections.” Dr. Bertucci explained the facial feedbac
- 2025 AAD: Treating Hyperpigmented and Hypertrophic Scars with Microneedling in Skin of Colorhttps://modernaesthetics.com/news/2025-aad-treating-hyperpigmented-and-hypertrophic-scars-with-microneedling-in-skin-of-color/2473758/Robyn Siperstein, MD, FAAD, presented “Use of Microneedling in Skin of Color: Treating Hyperpigmented and Hypertrophic Scars” at the 2025 American Academy of Dermatology Annual Meeting Sunday. “The key to this treatment and how I’ve really changed my anti-aging treatments are two things:
- 2025 AAD Meeting: Innovations for Treatment of Burn and Trauma Scarshttps://modernaesthetics.com/news/2025-aad-meeting-innovations-for-treatment-of-burn-and-trauma-scars/2473755/The use of lasers and energy-based device technology to treat different types of scars continues to evolve. Arielle N.B. Kauvar, MD, FAAD; Kristen Marie Kelly, MD, FAAD; Girish S. Munavalli, MD, MHS, FAAD; and Jill Waibel, MD, FAAD, explored the traditional and cutting-edge techniques for correct
- 2025 AAD: New Technologies for Face and Body Treatmentshttps://modernaesthetics.com/news/2025-aad-new-technologies-for-face-and-body-treatments-1/2473754/Skin tightening, innovations for cellulite and contouring, muscle stimulation methods, and hair restoration technology were the topics of “New Technologies for the Face and Body” presented by Neil Sadick, MD, FACP, FAACS, FACPh, FAAD, during the “Future of Cosmetic Dermatology” session at the 202
- Research Letter: Molecule Enhances Skin Barrier, Reduces Retinoid Side Effectshttps://modernaesthetics.com/news/research-letter-molecule-enhances-skin-barrier-reduces-retinoid-side-effects/2473752/A formulation containing Epicutis Skincare’s proprietary TSC molecule significantly reduced erythema and dryness caused by tretinoin, according to a research letter published in the Journal of Cosmetic Dermatology. The
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://modernaesthetics.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical use with
- Closing the Healthcare Gender Gap as a Key to Optimize Female Longevityhttps://modernaesthetics.com/news/closing-the-healthcare-gender-gap-as-a-key-to-optimize-female-longevity/2473748/"The story of women's struggle for equality belongs to no single feminist nor to any one organization but to the collective efforts of all who care about human rights." —Gloria Steinem The United Nations has declared the theme for this year’s International
- LaserAway, Rejuran Partner to Bring Leading South Korea Skin Booster to UShttps://modernaesthetics.com/news/laseraway-rejuran-partner-to-bring-south-koreas-no-1-skin-booster-to-us-1/2473746/A leading South Korean salmon DNA-based treatment will soon be available in the US under a new partnership announced by Rejuran. LaserAway, an aesthetic practice with more than 175 locations across the country, will help drive Rejuran’s first major US market entry, according to a
- 2025 Octane Aesthetics Tech Forum: The Growth of Hair Panelhttps://modernaesthetics.com/news/the-growth-of-hair-2025-octane-aesthetics-tech-forum/2473741/The Growth of Hair panel at the 2025 Octane Aesthetics Tech Forum brought together leading experts in dermatology, pharmacology, and regenerative medicine to discuss exciting advancements in hair loss treatments and technologies. The panel included Ken Washenik, MD; Wajdie Ahmad, Co-Founder &
- FDA Approves New HA Gels From Evolushttps://modernaesthetics.com/news/fda-approves-new-ha-gels-from-evolus/2473740/The US Food and Drug Administration has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, Evolus announced. These approvals mark Evolus’ entry into the United States HA dermal filler market and solidifies the com